Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma
Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff, et al.
Haematologica (2010) Vol. 95, Iss. 4, pp. 613-621
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 205.e1-205.e16
Closed Access | Times Cited: 353
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Sarah McCue Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 223.e1-223.e17
Closed Access | Times Cited: 326
Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
Changgeng Qian, Cheng-Jung Lai, Rudi Bao, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 15, pp. 4104-4113
Open Access | Times Cited: 212
The PIM Family of Serine/Threonine Kinases in Cancer
Maja Narlik‐Grassow, Carmen Blanco‐Aparicio, Amancio Carnero
Medicinal Research Reviews (2013) Vol. 34, Iss. 1, pp. 136-159
Closed Access | Times Cited: 205
Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities
Carmen Blanco‐Aparicio, Amancio Carnero
Biochemical Pharmacology (2012) Vol. 85, Iss. 5, pp. 629-643
Closed Access | Times Cited: 148
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
Michael Dickinson, Ricky W. Johnstone, H. Miles Prince
Investigational New Drugs (2010) Vol. 28, Iss. S1, pp. 3-20
Open Access | Times Cited: 137
Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
Robert W. Robey, Arup R. Chakraborty, Agnès Basseville, et al.
Molecular Pharmaceutics (2011) Vol. 8, Iss. 6, pp. 2021-2031
Open Access | Times Cited: 124
Targeting Histone Deacetylases in Diseases: Where Are We?
Rosaria Benedetti, Mariarosaria Conte, Lucia Altucci
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 99-126
Open Access | Times Cited: 110
Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas
Qing Zhang, Shaobin Wang, Junhui Chen, et al.
International Journal of Medical Sciences (2019) Vol. 16, Iss. 3, pp. 424-442
Open Access | Times Cited: 78
Recent Update of HDAC Inhibitors in Lymphoma
I‐Chung Chen, Bidyadhar Sethy, Jing‐Ping Liou
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 73
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
Cristina Gómez‐Abad, Helena Pisonero, Carmen Blanco‐Aparicio, et al.
Blood (2011) Vol. 118, Iss. 20, pp. 5517-5527
Open Access | Times Cited: 102
The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL‐10 expression in cutaneous T‐cell lymphoma cells
CE Tiffon, J E Adams, Leslie van der Fits, et al.
British Journal of Pharmacology (2010) Vol. 162, Iss. 7, pp. 1590-1602
Open Access | Times Cited: 92
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Mengyuan Ji, Yao‐Hui Huang, Jinyan Huang, et al.
Haematologica (2018) Vol. 103, Iss. 4, pp. 679-687
Open Access | Times Cited: 80
HDAC Inhibitors For The Treatment Of Cutaneous T-Cell Lymphomas
Sophia Rangwala, Chunlei Zhang, Madeleine Duvic
Future Medicinal Chemistry (2012) Vol. 4, Iss. 4, pp. 471-486
Closed Access | Times Cited: 65
HDAC modulation and cell death in the clinic
Carmela Dell’Aversana, Ilaria Lepore, Lucia Altucci
Experimental Cell Research (2012) Vol. 318, Iss. 11, pp. 1229-1244
Closed Access | Times Cited: 61
Epigenetics in fibrosis
Steven O’Reilly
Molecular Aspects of Medicine (2016) Vol. 54, pp. 89-102
Closed Access | Times Cited: 60
Romidepsin in peripheral and cutaneous T‐cell lymphoma: mechanistic implications from clinical and correlative data
Susan E. Bates, Robin A. Eisch, Alexander Ling, et al.
British Journal of Haematology (2015) Vol. 170, Iss. 1, pp. 96-109
Open Access | Times Cited: 59
Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
Brianne M. Cruickshank, Michael Giacomantonio, Paola Marcato, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 50
Epigenetic Targets and their Inhibitors in Cancer Therapy
Le Zhao, Yongtao Duan, Ping Lü, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 18, Iss. 28, pp. 2395-2419
Closed Access | Times Cited: 45
Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention
Srimanta Patra, Prakash Priyadarshi Praharaj, Daniel J. Klionsky, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 269-279
Open Access | Times Cited: 36
Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
Amit Kumar, Luni Emdad, Paul B. Fisher, et al.
Advances in cancer research (2023), pp. 73-161
Closed Access | Times Cited: 15
HDAC10 and its implications in Sézary syndrome pathogenesis
Monika Pieniawska, Karolina Rassek, Bogumiła Skwara, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Targeting histone deacetyalses in the treatment of B- and T-cell malignancies
Jasmine Zain, Owen A. O’Connor
Investigational New Drugs (2010) Vol. 28, Iss. S1, pp. 58-78
Open Access | Times Cited: 59
Apoptosis Induction by SAHA in Cutaneous T-Cell Lymphoma Cells Is Related to Downregulation of c-FLIP and Enhanced TRAIL Signaling
Nadya Al‐Yacoub, Lothar F. Fecker, Markus Möbs, et al.
Journal of Investigative Dermatology (2012) Vol. 132, Iss. 9, pp. 2263-2274
Open Access | Times Cited: 54
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
Janet Y. Li, Steven Horwitz, Alison J. Moskowitz, et al.
Cancer Management and Research (2012), pp. 75-75
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top